Safety and Immune Response of Different Pediatric Combination Vaccines.
Public ClinicalTrials.gov record NCT00255047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparative Immunogenicity of Different Multivalent Component Pertussis Vaccine Formulations Based on a 5 Component Acellular Pertussis Vaccine in Infants and Toddlers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The overall aim of the study is to corroborate that a schedule consisting of 3 doses of Pentacel™ and a 4th dose of DAPTACEL® and ActHIB® or 4 doses of Pentacel™ or 4 doses of Quadracel and ActHIB® is as safe and immunogenic as a standard of care schedule based on 3 doses of the licensed-equivalent vaccines DAPTACEL®, Vero cell derived Inactivated Poliovirus vaccine (IPOL®), and ActHIB® and a 4th dose of DAPTACEL® and ActHIB®.
Study identification
- NCT ID
- NCT00255047
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,167 participants
Conditions and interventions
Conditions
Interventions
- DAPTACEL®. (DTaP), IPOL®., and ActHIB®. Biological
- Pentacel®: DTaP-IPV/Hib combined Biological
- DTaP-IPV and ActHIB® Biological
Biological
Eligibility (public fields only)
- Age range
- 42 Days to 89 Days
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2005 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Feb 2009 (Actual)
- Last update posted
- Feb 14, 2014
2005 – 2009
United States locations
- U.S. sites
- 36
- U.S. states
- 20
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tuscaloosa | Alabama | 35401 | — |
| Not listed | Fayetteville | Arkansas | 72703 | — |
| Not listed | Jonesboro | Arkansas | 72401 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Fountain Valley | California | — | — |
| Not listed | Oakland | California | 94609 | — |
| Not listed | Oakland | California | 94613 | — |
| Not listed | Oakland | California | 94618 | — |
| Not listed | Paramount | California | 90723 | — |
| Not listed | Norwich | Connecticut | 06360 | — |
| Not listed | Palm Beach Gardens | Florida | 33410 | — |
| Not listed | Marietta | Georgia | 30062 | — |
| Not listed | Bardstown | Kentucky | 40004 | — |
| Not listed | Bossier City | Louisiana | 71111 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Woburn | Massachusetts | 01801 | — |
| Not listed | Omaha | Nebraska | 68131 | — |
| Not listed | Ithaca | New York | — | — |
| Not listed | Liverpool | New York | 13088 | — |
| Not listed | Huber Heights | Ohio | 45424 | — |
| Not listed | Youngstown | Ohio | 44514 | — |
| Not listed | Norristown | Pennsylvania | 19401 | — |
| Not listed | Pittsburgh | Pennsylvania | 15227 | — |
| Not listed | Pittsburgh | Pennsylvania | 15241 | — |
| Not listed | Kingsport | Tennessee | 37660 | — |
| Not listed | Amarillo | Texas | 79124 | — |
| Not listed | Fort Worth | Texas | 76107 | — |
| Not listed | San Antonio | Texas | 78205 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Provo | Utah | 84604 | — |
| Not listed | South Jordan | Utah | 84095 | — |
| Not listed | St. George | Utah | 84790 | — |
| Not listed | Spokane | Washington | 99216 | — |
| Not listed | Vancouver | Washington | 98664 | — |
| Not listed | Huntington | West Virginia | 25701 | — |
| Not listed | Marshfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00255047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 14, 2014 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00255047 live on ClinicalTrials.gov.